Competing in the 2016-2020 Global Cancer Diagnostics Market

Date: May 6, 2016
Pages: 1200
Price:
US$ 32,500.00
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C9C17F638A8EN
Leaflet:

Download PDF Leaflet

Competing in the 2016-2020 Global Cancer Diagnostics Market
This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. The new report contains 1,200 pages, 450 tables, and provides test volume and sales forecasts for major tumor markers, as well as supplier sales and shares by test, market segment and country. Available by country and section. Highlights- Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging tumor markers- Analyzes applications of emerging diagnostic technologies- Forecasts sales of major tumor markers by country and market segment- Profiles leading market players and potential entrants - Suggests alternative business expansion strategies for suppliers.RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.Geographic Coverage- France- Germany- Italy- Japan- Spain- UK- USAMarket Segmentation Analysis
  • Sales and market shares of major suppliers, by individual tumor markerand country.
  • Five-year test volume and sales forecasts for majortumor markers by country and market segment,including:
    • Hospitals
    • Commercial/Private Laboratories
    • Physician Offices/Group Practices
    • Cancer Clinics
    • Ambulatory Care Centers
  • Comprehensive market segmentation analysis, including reviewof the market dynamics, structure, size, growth and major suppliersby country.
  • Cancer statistics, etiology and recent developments in the U.S., Japan and five major European countries.
Current and Emerging Products
  • Review of over 200 current and emerging tumor markers,including:
    • Biochemical Markers
    • Oncogenes
    • Growth Factors
    • Hormones
    • Colony Stimulating Factors
    • Lymphokines
    • Immunohistochemical Stains, and others.
  • Analysis of major immunoassay analyzers used fortumor marker testing, including their operating characteristics,features and selling prices.
Technology Review- Assessment of monoclonal antibodies, immunoassays, DNAprobes, biochips/microarrays, chromosome analysis, IT,artificial intelligence, flow cytometry, biosensors, and theirpotential applications for tumor marker testing.- Review of competing/complementing technologies, includingCT, MRI, NMR, PET and photonics spectroscopy.- Extensive listings of over 500 companies, universities andresearch centers developing new tumor markers and detection technologies.Competitive Assessments- Extensive strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborativearrangements and new products in R D.Worldwide Market Overview- Estimated universe of laboratories performing tumor marker testingby country.- Five-year test volume and sales projections by country.Business Opportunities and Strategic Recommendations- Specific new product development opportunities with potentiallysignificant market appeal during the next five years.- Design criteria for new products.- Alternative market penetration strategies.
  • Potential market entry barriers and risks.MethodologyThis report is based on interviews with clinical pathologists, laboratory directors,executives from leading diagnostic companies and start-up firmsdeveloping innovative products, university scientists, as well asexperts from industry associations, venture capital firms and theinvestment banking community in the U.S., five major Europeancountries and Japan. The market projections are also based on questionnaireresponses received from hospitals, commercial/private laboratories,physician offices/group practices, cancer clinics and ambulatorycare centers in seven countries.In addition to primary sources of information, a comprehensivereview of the most recent technical and business publications, manufacturerproduct literature, patents, trade association surveys, governmentstudies, marketing and technical meeting presentations,industry analyst reports, and VPGMarketResearch.com's proprietary data files was conducted.

    Contains 1,200 pages and 450 tables
  • 1. INTRODUCTION

    2. WORLDWIDE MARKET OVERVIEW

      1. MARKET OVERVIEW
      2. WORLDWIDE MARKET STRUCTURE
      3. WORLDWIDE MARKET SIZE AND GROWTH

    3. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    A. Reagent Kits and Test Systems/Panels
    B. Instrumentation
    C. Computers, Software and Automation
    D. Auxiliary Products

    4. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    5. ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies

    6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    7. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

    A. Cancer Statistics and Etiology
      1. BREAST CANCER
      2. LUNG CANCER
      3. COLON AND RECTUM CANCER
      4. PROSTATE CANCER
      5. STOMACH CANCER
      6. LEUKEMIA
      7. LYMPHOMA
      8. ORAL CANCER
      9. SKIN CANCER
      10. UTERINE CANCER
      11. OVARIAN CANCER
      12. BLADDER CANCER
    B. Major Current And Emerging Cancer Diagnostic Tests
      1. INTRODUCTION
      2. TUMOR MARKER CLASSIFICATION
      3. ACTH
      4. ALPHA FETOPROTEIN (AFP)
      5. BETA 2 MICROGLOBULIN
      6. CA 15 3/27.29
      7. CA 199
      8. CA 125
      9. CALCITONIN
      10. CARCINOEMBRIONIC ANTIGEN (CEA)
      11. ESTROGEN AND PROGESTERONE RECEPTORS
      12. FERRITIN
      13. GASTRIN
      14. HUMAN CHORIONIC GONADOTROPIN (HCG)
      15. INSULIN
      16. NSE
      17. OCCULT BLOOD
      18. PAP SMEAR/HPV
      19. PROSTATIC ACID PHOSPHATASE (PAP)
      20. PROSTATE    SPECIFIC ANTIGEN (PSA)
      21. SQUAMOUS CELL CARCINOMA ANTIGEN (SCC)
      22. T AND B LYMPHOCYTES
      23. TDT
      24. THYROGLOBULIN
      25. TISSUE POLYPEPTIDE ANTIGEN (TPA)
      26. BIOCHEMICAL TUMOR MARKERS
      27. ONCOGENES
      Abl/abl bcr
      AIB1
      BCL2
      BRCA1
      CD44
      C-fos
      C-myb
      C-myc
      CYP    17
      ErbB
      HPC1
      Nmyc
      P40
      P51
      P53
      PIK3CA
      PTI1
      Ras
      Reg
      Sis
      Src
      28. POLYPEPTIDE GROWTH FACTORS
      Basic Fibroblast Growth Factor
      Beta    TGF
      Cachectin (TNT)
      Calmodulin
      ECFR
      Nerve Growth Factor (NGF)
      Epidermal Growth Factor (EGF)
      Ornithine Decarboxylase
      Transferrin
      Transforming Growth Factor    Alpha
      29. ECTOPIC HORMONES
      30. COLONY STIMULATING FACTORS
      31. LYMPHOKINES
      Alpha    Interferon
      B Cell Growth Factors
      B Cell Growth Factor (BCGF)
      Gamma    Interferon
      Interleukin    1 (IL1)
      Macrophage Activating Factor
      32. IMMUNOHISTOCHEMICAL STAINS
      33. EMERGING TUMOR MARKERS
      NAcetylglucosamine
      Actin
      Alpha    Actin
      Antineuronal Antibodies
      7B2
      B72.3
      Bax
      BCD    F9
      BLCA 4
      Blood Group Antigens A, B, H
      CA
      CA 72    4/TAG    72
      CA
      CA 242
      CA 549
      CAM
      CAR    3
      Cathepsin    D
      Chromogranin A and B
      Cluster 1 Antigen
      Cluster    5/5A Antigen
      CTA
      CU18
      DR    70
      DU    AN2
      Endometrial Bleeding Associated Factor
      Endostatin
      Epithelial Membrane Antigen
      Feulgen Hydrolysis
      Fibronectin
      FSH
      (1    >3)    Lfucosyltransferase
      Gastrin    Releasing Peptide (GRP)
      GDCFP    15
      Glucagon
      Glycoamines
      H23
      Her    2
      Human Carcinoma Antigen
      HPA
      HSP27
      Intermediate Filaments
      Cytokeratins/CK18/Cyfra 21    1
      Desmin
      Gliofibrillary Acid Protein
      Neurofilaments
      Vimentin
      KA
      Kinases
      KP16D3
      LAI
      Leukocyte Common Antigen
      Lewis Antigens
      Lysophosphatidic Acid (LPA)
      Ma 695/Ma
      MABDF3
      MAG
      ME1
      Minactivin
      MN/CA9
      MSA
      Mucin Cancer Antigen (MCA)
      Multiple Tumor Suppressor
      Myosin
      NEA 130
      NMP22
      OA 519
      Opioid Peptides
      P    glycoprotein
      Pancreatic Oncofetal Antigen (POA)
      Placental Lactogen
      PR92
      Proliferative Index, Ki 67
      Px
      RB Inactivation/Deletion
      Ret
      SCCL
      Selectin
      Sialic Acid
      Sialyl SSEA 1/SLX
      SN10
      Somatostatin
      TA 90
      TABA
      Tachykinin
      TAG
      TPS
      Troponin
      Tubulin
      VCAM
      VEGF
      Villen
    C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
    D. Current and Emerging Cancer Diagnostic Technologies
      1. MONOCLONAL AND POLYCLONAL ANTIBODIES
      2. IMMUNOASSAYS
      3. MOLECULAR DIAGNOSTICS
      4. CHROMOSOME ANALYSIS
        a. Chronic Myelogenous Leukemia (CML)
        b. Acute Myeloid Leukemia (AML)
        c. Acute Lymphoblastic Leukemia (ALL)
        d. Malignant Lymphomas Lymphoid Malignancies
        e. Chronic Lymphocytic Leukemia (CLL)
        f. Solid Cancers
        g. Chromosomal Translocation and Oncogenes
      5. ARTIFICIAL INTELLIGENCE
      6. FLOW CYTOMETRY
      7. TW DIMENSIONAL GEL ELECTROPHORESIS (2    DGE)
      8. BIOSENSORS
      9. COMPETING/COMPLEMENTING TECHNOLOGIES
    E. Personal Testing

    8. FRANCE CANCER DIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

    9. GERMANY CANCER DIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

    10. ITALY CANCER DIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

    11. JAPAN CANCER DIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

    12. SPAIN CANCER DIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

    13. U.K. CANCER DIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

    14. U.S. CANCER DIAGNOSTICS MARKET

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

    15. COMPETITIVE PROFILES

      Abbott
      AdnaGen/Alere
      Agilent Technologies
      Applied Gene Technologies
      Arca Biopharma
      Beckman Coulter/Danaher
      Becton Dickinson
      Biomedical Diagnostics
      bioMerieux
      Bio-Rad
      CellSearch
      Cepheid
      Correlogic Systems/Vermillion
      Decode Genetics
      Diadexus
      Diagnocure
      Diasorin
      Eiken Chemical
      Elitech Group
      Enterix
      Enzo Biochem
      Epigenomics
      Exact Sciences
      Fujirebio
      Guided Therapeutics
      Hologic/Genrobe
      Kreatech/Leica
      Kyowa Medex
      Mackay Life Sciences
      Myriad Genetics
      OncoLab
      Ortho    Clinical Diagnostics
      Panacea Pharmaceuticals
      Polartechnics
      Polymedco
      PreMD
      Qiagen
      Quest Diagnostics
      Radient Pharmaceuticals
      Roche
      Scienion
      Sequenom
      Siemens Healthcare
      Takara Bio
      Targeted Diagnostics & Therapeutics
      Tosoh
      Thermo
      Veridex
      Wako Pure Chemicals
      Wallac/PE
      Zila

    16. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS

    LIST OF TABLES

    Tumor Marker Classification
    Major Companies Developing or Marketing ACTH Tests
    Major Companies Developing or Marketing AFP Tests
    Major Companies Developing or Marketing Beta    2 Microglobulin Tests
    Major Companies Developing or Marketing CA 15 3/27.29 Tests
    Major Companies Developing or Marketing CA 199 Tests
    Major Companies Developing or Marketing CA 125 Tests
    Major Companies Developing or Marketing Calcitonin Tests
    Major Companies Developing or Marketing CEA Tests
    Major Companies Developing or Marketing Estrogen Receptor Tests
    Major Companies Developing or Marketing Progesterone Receptor Tests
    Major Companies Developing or Marketing Ferritin Tests
    Major Companies Developing or Marketing Gastrin Tests
    Major Companies Developing or Marketing HCG Tests
    Major Companies Developing or Marketing Insulin Tests
    Major Companies Developing or Marketing NSE Tests
    Major Companies Developing or Marketing Occult Blood Tests
    Major Companies Developing or Marketing PAP Smear/HPV Tests
    Major Companies Developing or Marketing PAP Tests
    Major Companies Developing or Marketing PSA Tests
    Major Companies Developing or Marketing Lymphocyte Subclassification Tests
    Biochemical Markers Potential Applications In Cancer Diagnosis
    Oncogenes Potential Applications In Cancer Diagnosis
    Major Companies Developing or Marketing Oncogene Tests
    Growth Factors Potential Applications In Cancer Diagnosis
    Colony Stimulating Factors Potential Applications in Cancer Diagnosis
    Lymphokines Potential Applications In Cancer Diagnosis
    Immunohistochemical Stains Potential Applications in Cancer Diagnosis
    Executive Summary Table: France, Total Cancer Diagnostic Test Volume and Sales Forecast by Market Segment
    France, Estimated Cancer Death Rates Per 100, 000 Population
    France, Laboratories Performing Tumor Marker Tests by Market Segment
    France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
    France, Total Tumor Marker Test Volume Forecast by Market Segment
    France, All Market Segments Major Tumor Marker Test Volume Forecast
    France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
    France, Commercial/Private Laboratories Marker Test Volume Forecast
    France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
    France, All Market Segments Major Tumor Marker Sales Forecast by Test
    France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    France, Commercial/Private Laboratories Cancer
    Diagnostics Market Forecast by Test
    France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, CA 199 Test Volume and Diagnostics Sales Forecast by Market
    France, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
    France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Colon    Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
    France, Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Ferritin Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Gastrin Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Insulin Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Interferons Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Interleukins Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
    France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    France, PAP Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
    France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    France, S    100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
    France, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment
    France, Thyroglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
    France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    France, Total Tumor Marker Sales By Major Suppliers
    France, AFP Testing Market Diagnostics Sales by Major Supplier
    France, CA 15 3 Testing Market Diagnostics Sales by Major Supplier
    France, CA 199 Testing Market Diagnostics Sales by Major Supplier
    France, CA 125 Testing Market Diagnostics Sales by Major Supplier
    France, CEA Testing Market Diagnostics Sales by Major Supplier
    France, NSE Testing Market Diagnostics Sales by Major Supplier
    France, PAP Testing Market Diagnostics Sales by Major Supplier
    France, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
    Germany, Estimated Cancer Death Rates Per 100, 000 Population
    Germany, Laboratories Performing Tumor Marker Tests by Market Segment
    Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
    Germany, Total Tumor Marker Test Volume Forecast by Market Segment
    Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
    Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
    Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
    Germany, Total Tumor Marker Sales Forecast by Market Segment
    Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
    Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
    Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
    Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Beta    2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
    Germany, CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, CA 19 Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Calcitonin Test Volume And Diagnostic Sales Forecast by Market Segment
    Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
    Germany, Colon    Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
    Germany, Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Interferons Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Interleukins Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Pap Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
    Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, S    100 Protein Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
    Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Thymidine Kinase Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, Thyroglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    Germany, Total Tumor Marker Sales By Major Supplier
    Germany, AFP Testing Market Diagnostics Sales by Major Supplier
    Germany CA 15 3/27.29 Testing Market Diagnostics Sales by Major Supplier
    Germany CA 199 Testing Market Diagnostics Sales by Major Supplier
    Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
    Germany, CEA Testing Market Diagnostics Sales by Major Supplier
    Germany, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Estimated Cancer Death Rates Per 100, 000 Population
    Italy, Laboratories Performing Tumor Marker Tests by Market Segment
    Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
    Italy, Total Tumor Marker Test Volume Forecast by Market Segment
    Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
    Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
    Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    Italy, Total Tumor Marker Test Market Forecast by Market Segment
    Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
    Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
    Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Beta    2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
    Italy, CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
    Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
    Italy, Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
    Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
    Italy, PAP Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, Progesterone Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, S    100 Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
    Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Thymidine Kinase Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, Thyroglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    Italy, Total Tumor Markers Sales by Major Suppliers
    Italy, AFP Testing Market Diagnostics Sales by Major Supplier
    Italy, CEA Testing Market Diagnostics Sales by Major Supplier
    Italy, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: Japan, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
    Japan, Estimated Cancer Death Rates Per 100, 000 Population
    Japan, Laboratories Performing Tumor Marker Tests by Market Segment
    Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    Japan, Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
    Japan, Total Tumor Marker Testing Volume Forecast by Market Segment
    Japan, All Market Segments Major Tumor Marker Test Volume Forecast
    Japan, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
    Japan, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    Japan, Total Tumor Marker Sales Forecast by Market Segment
    Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
    Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    Japan, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Chromogranin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Colon    Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
    Japan, Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Ferritin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Gastrin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Interferons Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Interleukins Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Nucleolar Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, PAP Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, S    100 Protein Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
    Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Japan, TPA, Test Volume and Diagnostics Sales Forecast by Market Segment
    `Japan, Total Tumor Marker Sales by Major Suppliers
    Japan, AFP Testing Market Diagnostics Sales by Major Supplier
    Japan, CA 15 3/27.29 Testing Market Diagnostics Sales by Major Supplier
    Japan, CA 199 Testing Market Diagnostics Sales by Major Supplier
    Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
    Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
    Japan, PAP Testing Market Diagnostics Sales by Major Supplier
    Japan, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
    Spain, Estimated Cancer Death Rates Per 100, 000 Population
    Spain, Laboratories Performing Tumor Marker Tests by Market Segment
    Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
    Spain, Total Tumor Marker Test Volume Forecast by Market Segment
    Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
    Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
    Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    Spain, Total Tumor Marker Sales Forecast by Market Segment
    Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
    Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Spain, CA 15 3 Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Colon    Specific Antigen Test Volumeand Diagnostics Sales Forecast by Market Segment
    Spain, Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
    Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
    Spain, Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
    Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, PAP Smear Test Volumeand Diagnostics Sales Forecast by Market Segment
    Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecast by Market Segment
    Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, S    100 Protein Test Volume And Diagnostics Sales Forecast by Market Segment
    Spain, Serotonin Test Volumeand Diagnostics Sales Forecast by Market Segment
    Spain, Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
    Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    Spain, Total Tumor Marker Sales by Major Suppliers
    Spain, AFP Testing Market Diagnostics Sales by Major Supplier
    Spain, CA 15 3/27.29 Testing Market Diagnostics Sales by Major Supplier
    Spain, 199 Testing Market Diagnostics Sales by Major Supplier
    Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
    Spain, CEA Testing Market Diagnostics Sales by Major Supplier
    Spain, PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
    U.K., Estimated Cancer Death Rates Per 100, 000 Population
    U.K., Laboratories Performing Tumor Marker Tests by Market Segment
    U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
    U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
    U.K., All Market Segments Major Tumor Marker Test Volume Forecast
    U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
    U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    U.K., Total Tumor Marker Sales Forecast by Market Segment
    U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
    U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Calcitonin Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Colon    Specific Antigen Test Volume And Diagnostics Sales by Market Segment
    U.K., Cytokeratins Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., Estrogen Receptor Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., Ferritin Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Occult Blood Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., Oncogenes Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., S    100 Protein Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Sialic Acid Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.K., Total Tumor Marker Salesand Market Shares Forecast
    U.K., CEA Testing Market Diagnostics Sales by Major Supplier
    U.K., PSA Testing Market Diagnostics Sales by Major Supplier
    Executive Summary Table: U.S., Total Tumor Marker Test Volume and Sales Forecast By Market Segment
    U.S., Estimated New Cancer Cases and Deaths
    U.S., Estimated Cancer Death Rates Per 100, 000 Population
    U.S., Laboratories Performing Tumor Marker Tests by Market Segment
    U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
    U.S., Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
    U.S., Physician Office Laboratories Performing Tumor Marker Tests by Practice Size
    U.S., Total Tumor Marker Test Volume Forecast by Market Segment
    U.S., All Market Segments Major Tumor Marker Test Volume Forecast
    U.S., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
    U.S., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
    U.S., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
    U.S., Cancer Clinics Major Tumor Marker Test Volume Forecast by Test
    U.S., Total Tumor Marker Sales Forecast by Market Segment
    U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
    U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
    U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
    U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
    U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
    U.S., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Beta    2 Microglobulin Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.S., CA 15 3/27.29 Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.S., CA 199 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Calcitonin Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.S., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., CEA Test Volume and Diagnostics Sales by Market Segment
    U.S., Chromogranin Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.S., Colon    specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
    U.S., Cytokeratins Test Volume And Diagnostics Sales Forecast by Market Segment
    U.S., Estrogen Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
    U.S., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Interferons Test Volume And Diagnostics Sales Forecast by Market Segment
    U.S., Interleukins Test Volume And Diagnostics Sales Forecast by Market Segment
    U.S., Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.S., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Occult Blood Test Volume And Diagnostics Sales Forecast by Market Segment
    U.S., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., S    100 Protein Test Volumeand Diagnostics Sales Forecast by Market Segment
    U.S., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
    U.S., Total Tumor Marker Sales By Major Supplier
    U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
    U.S., AFP Testing Market Diagnostics Sales by Major Supplier
    U.S., Beta    2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
    U.S., CA 15 3/27.29 Testing Market Diagnostics Sales by Major Supplier
    U.S., CA 199 Testing Market Diagnostics Sales by Major Supplier
    U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
    U.S., CEA Testing Market Diagnostics Sales by Major Supplier
    U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
    U.S., HCG Testing Market Diagnostics Sales by Major Supplier
    U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
    U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
    U.S., PAP Testing Market Diagnostics Sales by Major Supplier
    U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
    U.S., PSA Testing Market Diagnostics Sales by Major Supplier
    Skip to top


    Ask Your Question

    Competing in the 2016-2020 Global Cancer Diagnostics Market
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: